133 related articles for article (PubMed ID: 1915646)
21. [Toxic adenoma. Study of 35 cases].
Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
[No Abstract] [Full Text] [Related]
22. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.
Kinser JA; Roesler H; Furrer T; Grütter D; Zimmermann H
J Nucl Med; 1989 Dec; 30(12):1960-5. PubMed ID: 2585096
[TBL] [Abstract][Full Text] [Related]
23. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
Abós MD; Banzo J; Razola P; García F; Prats E
Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
[TBL] [Abstract][Full Text] [Related]
24. [Radioiodine (131I) as the only treatment of hyperthyroidism. Results of 10 years of experience].
Hennen G; McNamara EM; Dockier A; Joachim M
Rev Med Liege; 1999 Jul; 54(7):611-7. PubMed ID: 10495684
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of the cytokines IL-1beta, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter.
Nygaard B; Jarløv AE; Kristensen LO; Faber J
Horm Metab Res; 2000 Jul; 32(7):283-7. PubMed ID: 10965935
[TBL] [Abstract][Full Text] [Related]
26. [Results obtained in the treatment of hyperfunctional thyroid adenomas with I-131].
Holan T; Micluţia M; Derevenco V
Stud Cercet Endocrinol; 1972; 23(4):271-9. PubMed ID: 4681160
[No Abstract] [Full Text] [Related]
27. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
28. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage].
Moser E
Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115
[TBL] [Abstract][Full Text] [Related]
29. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
[TBL] [Abstract][Full Text] [Related]
30. [Radioisotope therapy of hyperthyroidism].
Englaro GC; Zecchin R
Minerva Med; 1973 Apr; 64(25):1347-56. PubMed ID: 4740096
[No Abstract] [Full Text] [Related]
31. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
[TBL] [Abstract][Full Text] [Related]
32. [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)].
Mertz DP; Koch B
MMW Munch Med Wochenschr; 1977 Jul; 119(28):945-8. PubMed ID: 408626
[TBL] [Abstract][Full Text] [Related]
33. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
Hoeschel M; Heinze HG
Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
[TBL] [Abstract][Full Text] [Related]
34. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre.
Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR
N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075
[TBL] [Abstract][Full Text] [Related]
35. [Status of 3 years of hyperthyroidism treatment with iodine 131].
Delgrange E; Weber E; Michel L; De Coster P; Buysschaert M; Donckier J
Acta Clin Belg; 1994; 49(5):200-7. PubMed ID: 7992563
[TBL] [Abstract][Full Text] [Related]
36. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
Berding G; Schicha H
Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
[TBL] [Abstract][Full Text] [Related]
37. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
[TBL] [Abstract][Full Text] [Related]
38. [The effective half-life of 131I during the treatment of autonomous thyroid disease with radioiodine].
Müller B; Bares R; Büll U
Nuklearmedizin; 1991 Jun; 30(3):71-6. PubMed ID: 1714566
[TBL] [Abstract][Full Text] [Related]
39. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
[TBL] [Abstract][Full Text] [Related]
40. [The treatment of hyperthyroidism with and indication for radioactive iodine].
Klokke AR; van der Vijver JC
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
